COMMUNIQUÉS West-GlobeNewswire

-
OncoC4 Announces New Preclinical Data Highlighting ONC-841, a Novel SIGLEC 10 Antibody, as a Potential New Class of Therapeutics for Alzheimer’s Disease
28/07/2025 -
Apyx Medical Corporation Announces Launch of Renuvion® in China
28/07/2025 -
Chiesi Global Rare Diseases Spotlights the Profound Impact of Epidermolysis Bullosa in the Film “Living Between Pain and Hope” as part of “The Next Frontier,” a New Series Presented by the Biotechnology Innovation Organization
28/07/2025 -
Soleno Therapeutics to Report Second Quarter 2025 Financial Results on August 6, 2025, at 4:30 PM ET
28/07/2025 -
UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology
28/07/2025 -
Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025
28/07/2025 -
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
28/07/2025 -
NetraMark Signs Contract with AlgoTx to Enhance Clinical Trial Design for ATX01
28/07/2025 -
Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy
28/07/2025 -
Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025
28/07/2025 -
Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic
28/07/2025 -
Dogecoin Cash Inc. Confirms Filing of Provisional Patent for Dogecoin Protocol Framework
28/07/2025 -
Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC
28/07/2025 -
Testosterone Booster for Muscle Gain: Men Opt for OTC Supplement Form Natural Testosterone Replacement Therapy (TRT) Treatment in 2025
27/07/2025 -
Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop
26/07/2025 -
ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.
26/07/2025 -
POP BIO and CEPI announce collaboration for faster responses to Disease X
25/07/2025 -
Movement Room Hits 250 Google 5-Star Reviews, Cementing Position as Best Physiotherapy Clinic in Vancouver
25/07/2025 -
NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups
25/07/2025
Pages